Literature DB >> 10628601

Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein.

C Martin1, X Viviand, P Saux, F Gouin.   

Abstract

OBJECTIVE: To determine the frequency of central venous catheter-induced thrombosis of the axillary vein.
DESIGN: Prospective, controlled study.
SETTING: Tertiary care university center. PATIENTS: Sixty patients in a medical-surgical intensive care unit who required central venous catheterization via the axillary vein.
INTERVENTIONS: Single-lumen, silicone elastomer or polyurethane catheters were inserted for a mean duration of 14.7+/-7.4 days (range, 4-33 days). On catheter removal, bilateral upper-extremity phlebographic examination was performed in each patient. The incidence of deep vein thrombosis in catheterized arms was compared with that in uncatheterized arms.
MEASUREMENTS AND MAIN RESULTS: Of the 60 patients who underwent axillary vein cannulation, one patient had clinical signs of arm vein thrombosis, but no patient had clinical sign of pulmonary embolism. There were 35 patients (58.3%) who developed positive phlebographic examinations homolateral to the catheter. Fibrin sleeves that developed around the catheters were observed in 28 patients (47%). Five patients (8.3%) had phlebographic signs of partial axillary vein thrombosis: nonobstructive clots adherent to the vessel wall and/or the catheter. Two patients (3.3%) had phlebographic signs of complete axillary vein thrombosis. No thrombosis was observed in patients with catheterizations lasting < or =6 days, two cases were observed for duration of 7-14 days, and five cases were observed for duration of > or =15 days (p < .01). In the seven patients with axillary vein thrombosis, the vessel was cannulated with fewer than three puncture attempts, and the mean duration for catheter insertion (10+/-2.5 min) was not different from that of patients with no axillary vein thrombosis (14+/-9 min).
CONCLUSIONS: Based on the data from the present study, we conclude that axillary vein catheterization is associated with a 11.6% frequency of upper-extremity deep vein thrombosis. This rate of vein thrombosis is similar to that observed after internal jugular or subclavian vein cannulation. Given the acceptable rate of this clinically important complication, axillary vein cannulation offers an attractive alternative site for catheter insertion to the internal jugular or subclavian vein in the critically ill. Because thrombosis is rare or absent in catheterizations lasting <15 days, it seems wise to withdraw axillary catheters after a maximum of 2 wks.

Entities:  

Mesh:

Year:  1999        PMID: 10628601     DOI: 10.1097/00003246-199912000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  Bilateral upper-extremity deep vein thrombosis following central cord syndrome.

Authors:  Hilal Onmez; Havva Turac Cingoz; Sami Kucuksen; Emel Anliacık; Ozan Yaşar; Halim Yilmaz; Ali Salli
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

3.  Deep venous thrombosis of the neck and pulmonary embolism in patients with a central venous catheter admitted to cardiac rehabilitation after cardiac surgery: a prospective study of 815 patients.

Authors:  Rino Frizzelli; Ornella Tortelli; Vincenzo Di Comite; Redenta Ghirardi; Claudio Pinzi; Cleante Scarduelli
Journal:  Intern Emerg Med       Date:  2008-03-21       Impact factor: 3.397

4.  Lipoma causing upper extremity deep vein thrombosis: a case report.

Authors:  Balavani Palamari; Jerome F Breen; Waldemar E Wysokinski
Journal:  J Thromb Thrombolysis       Date:  2009-08-29       Impact factor: 2.300

5.  Thrombosis associated with right internal jugular central venous catheters: A prospective observational study.

Authors:  Rash Kujur; S Manimala Rao; Gunjan Badwaik; Rajesh Paraswani
Journal:  Indian J Crit Care Med       Date:  2012-01

Review 6.  Clinical review: vascular access for fluid infusion in children.

Authors:  Nikolaus A Haas
Journal:  Crit Care       Date:  2004-06-03       Impact factor: 9.097

7.  Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women.

Authors:  Joel G Ray; Loralie J Langman; Marian J Vermeulen; Jovan Evrovski; Erik L Yeo; David EC Cole
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

Review 8.  Multidisciplinary approach and anesthetic management of a surgical cancer patient with methylene tetrahydrofolate reductase deficiency: a case report and review of the literature.

Authors:  Marco Cascella; Marco Mc Cascella; Manuela Arcamone; Manuela Ma Arcamone; Emanuela Morelli; Emanuela Em Morelli; Daniela Viscardi; Daniela Dv Viscardi; Viera Russo; Viera Vr Russo; Silvia De Franciscis; Silvia Sdf De Franciscis; Andrea Belli; Andrea Ab Belli; Rosanna Accardo; Rosanna Ra Accardo; Domenico Caliendo; Domenico Dc Caliendo; Elena De Luca; Elena Edl De Luca; Barbara Di Caprio; Barbara Bdc Di Caprio; Francesco Di Sauro; Francesco Fds Di Sauro; Giovanni Giannoni; Giovanni Gg Giannoni; Carmine Iermano; Carmine Ci Iermano; Maria Maciariello; Maria Mm Maciariello; Marcella Marracino; Marcella Mm Marracino; Arturo Cuomo; Arturo Ac Cuomo
Journal:  J Med Case Rep       Date:  2015-08-20

9.  Incidence and risk factors for central venous catheter-related thrombosis in hematological patients.

Authors:  Monika Joks; Anna Czyż; Dariusz Popławski; Mieczysław Komarnicki
Journal:  Med Oncol       Date:  2013-11-29       Impact factor: 3.064

10.  Subclavian central venous catheter-related thrombosis in trauma patients: incidence, risk factors and influence of polyurethane type.

Authors:  Ariane Gentile; Laurent Petit; Françoise Masson; Vincent Cottenceau; Josseline Bertrand-Barat; Geneviève Freyburger; Catherine Pinaquy; Alain Léger; Jean-François Cochard; François Sztark
Journal:  Crit Care       Date:  2013-05-29       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.